Special Issue

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

28 Oct 2016
Rosa A van Amerongen, Valesca P Retèl, Veerle MH Coupé, Petra M Nederlof, Maartje J Vogel, Wim H van Harten

Next-generation sequencing (NGS) has reached the molecular diagnostic laboratories. Although the NGS technology aims to improve the effectiveness of therapies by selecting the most promising therapy, concerns are that NGS testing is expensive and that the ‘benefits’ are not yet in relation to these costs. In this study, we give an estimation of the costs and an institutional and national budget impact of various types of NGS tests in non-small-cell lung cancer (NSCLC) and melanoma patients within the Netherlands. First, an activity-based costing (ABC) analysis has been conducted on the costs of two examples of NGS panels (small- and medium-targeted gene panel (TGP)) based on data of the Netherlands Cancer Institute (NKI). Second, we performed a budget impact analysis (BIA) to estimate the current (2015) and future (2020) budget impact of NGS on molecular diagnostics for NSCLC and melanoma patients in the Netherlands. Literature, expert opinions, and a data set of patients within the NKI (n = 172) have been included in the BIA. Based on our analysis, we expect that the NGS cost concerns will be limited. In the current situation, NGS can indeed result in higher costs, which is mainly related to required additional tests besides the small TGP. However, in the future, we expect that the use of whole-genome sequencing (WGS) will increase, for which it is expected that additional tests can by (partly) avoided. Although the current clinical benefits are expected to be limited, the research potentials of NGS are already an important advantage.

Article metrics: 2857 views

Related Articles

Dorothy C Lombe, Catherine K Mwaba, Susan C Msadabwe, Lewis Banda, Maurice Mwale, George Pupwe, Paul Kamfwa, Mulape Kanduza, Harry Munkupa, Biemba Maliti, Kalyoka Simbeye, Pious Hachizo, Lilie Lin, Elizabeth Chiao, Kennedy Lishimpi
Luis Larrea, Enrique López, Paola Antonini, Verónica González, Miguel Ángel Berenguer, Maria Carmen Baños, Jose Bea, Jose Domingo
Livio Blasi, Roberto Bordonaro, Nicolò Borsellino, Alfredo Butera, Michele Caruso, Stefano Cordio, Di Cristina Liborio, Francesco Ferraù, Dario Giuffrida, Hector Soto Parra, Massimiliano Spada, Paolo Tralongo, Roberto Valenza, Francesco Verderame, Stefano Vitello, Filippo Zerilli, Dario Piazza, Alberto Firenze, Vittorio Gebbia
Julia Ismael, Federico Losco, Sergio Quildrian, Pablo Sanchez, Isabel Pincemin, Jose Lastiri, Santiago Bella, Alejandro Chinellato, Guillermo Dellamea, Alejandro Ahualli, Silvana Rompato, Julio Velez, Rafael Escobar, Ariel Zwenger, Cristina Rosales, Claudia Bagnes, Jorge Puyol, Dario Niewiadomski, Edgardo Smecuol, Fabio Nachman, Eduardo Gonzalez, Gustavo Ferraris, Juan Ramos Suppicich, Paola Price, Luis Medina, Juan O’Connor
Akhil Kapoor, Vanita Noronha, Vijay M Patil, Amit Joshi, Nandini Menon, Abhishek Mahajan, Amit Janu, Kumar Prabhash
Mohammed Jawad, Christopher Millett, Richard Sullivan, Fadel Alturki, Bayard Roberts, Eszter P Vamos